On 6 January 2023, the Danish Maritime and Commercial High Court dismissed an application for remission to the Board of Appeal of the registration of a utility model. The court considered whether…
In an appeal of a PI decision, the Danish Eastern High Court has ruled to uphold the dismissal of Novartis’ application for a preliminary injunction against Glenmark, Zentiva, and Viatris, based on…
After four years of experience with Spanish Act 24/2015, of 24 July, on Patents (the "new Patent Act"), which came into force on 1 April 2017, the time seems ripe now to update some aspects of the…
On 14 October 2020, the Swiss Federal Council published a preliminary draft of a revised version of the Swiss Patent Act (R-PatA; see current PatA). Further official documents in German/Italian…
One of the remedies typically provided by patent law to persons whose inventions have been unduly patented by third parties are actions aimed at claiming ownership of the patent. However, such…
When the Kingdom of Spain joined what were then called the European Communities (the "EC") in 1986, it had to approve a new Patents Act which sought to adapt Spain's patent law to the standards…
On April 26 2017, the Eastern High Court of Denmark gave an interesting decision in a case between Orifarm Generics A/S and Novartis A/S, who is the holder of a patent and a number of utility models…
The new Spanish Patent Act, which will come into force on 1 April 2017, will introduce a modernised "utility model" that is expected to become the natural alternative for "non-examined" patents,…
